- Report
- October 2025
- 81 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- October 2025
- 87 Pages
Oman
From €4232EUR$4,500USD£3,531GBP
- Report
- May 2025
- 207 Pages
Global
From €4655EUR$4,950USD£3,884GBP
- Report
- May 2025
- 119 Pages
Global
From €2774EUR$2,950USD£2,314GBP
- Report
- May 2025
- 83 Pages
From €2774EUR$2,950USD£2,314GBP
- Report
- May 2025
- 98 Pages
Asia Pacific
From €3245EUR$3,450USD£2,707GBP
- Report
- May 2025
- 91 Pages
North America
From €2774EUR$2,950USD£2,314GBP
- Webinar
- July 2024
- 4 Hours
Global
From €692EUR$736USD£577GBP
- Report
- January 2026
- 160 Pages
Global
From €2972EUR$3,160USD£2,479GBP
€3715EUR$3,950USD£3,099GBP
- Report
- October 2024
- 94 Pages
Global
From €3500EUR$3,986USD£3,022GBP
-
Journal - November 2026
- 60 Pages
Global
From €400EUR$425USD£333GBP

The Drug Formulation market is a key component of the Drug Discovery process. It involves the development of a drug product that is suitable for administration to a patient. This includes the selection of the appropriate drug delivery system, the optimization of the drug's physical and chemical properties, and the development of a manufacturing process. The formulation of a drug is a complex process that requires expertise in a variety of disciplines, including chemistry, pharmacology, and engineering.
The Drug Formulation market is highly competitive, with a number of companies offering a range of services. These include formulation development, analytical testing, and manufacturing. Companies in the market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Show Less Read more